Further studies will be carried out to reveal the mechanisms underlying the effects of the MED14-HOXA9 fusion on the differentiation and proliferation of leukemia stem cells, as well as suitable treatment strategies for this rare disease. This evidence concerns the gene MED14 and leukemia.